Molecular imaging institute joins Waters’ innovation program

Skip to Navigation

Blog Post

  • Published: Jun 30, 2016
  • Author: Jon Evans
  • Source: Waters Corporation
  • Suppliers: Waters Corporation
  • Channels: Sample Preparation / Detectors / Proteomics & Genomics / Gas Chromatography / Ion Chromatography / Electrophoresis / Laboratory Informatics / HPLC / X-ray Spectrometry / UV/Vis Spectroscopy / Raman / Base Peak / NMR Knowledge Base / Chemometrics & Informatics / Proteomics / Atomic / Infrared Spectroscopy / MRI Spectroscopy

View comments on this post

Waters Corporation has inaugurated the Maastricht MultiModal Molecular Imaging (M4I) Institute in the Netherlands into its Centers of Innovation (COI) Program. Under the direction of Ron Heeren, the institute conducts research into applications for mass spectrometry in three main areas: oncology, neurology and cardiovascular medicine.

“In 2014, we welcomed Ron Heeren in Maastricht to become our university professor. The economy of Limburg benefits greatly from his innovative impulses to scientific developments and Prof. Heeren’s research group is of paramount importance for the growth and development of UM research,” said. Martin Paul, president of Maastricht University. “The M4I Institute, consisting of Heeren’s mass spectrometry lab and Peter Peters’s nanoscopy lab, is already one of the largest imaging centres in Europe. M4I expands already established imaging infrastructures such as Brains Unlimited, and improves Maastricht’s position as an international centre of excellence for human and molecular imaging even further.”

“Prof. Heeren is a true visionary and we are extremely pleased to welcome him into our COI Program,” said Eric Fotheringham, director of the Waters Centers of Innovation Program. “The fantastic work being done by the MultiModal Molecular Imaging Institute with the help of imaging mass spectrometry gives me a lot of optimism about medical science and the future of health care.”

For its research, the Institute employs three forms of mass spectrometry – mass spectrometry imaging (MSI) coupled with ion mobility and high spectral mass resolution. The scope of Heeren’s use of imaging mass spectrometry is wide-ranging. He uses it to determine where molecules of all types – lipids, intact proteins, endogenous peptides, drug metabolites – are localized within a tissue sample, and which are found in high concentrations and which are not. This is all in an effort to improve the understanding of disease progression and regression.

(Photo: (left to right) Ron Heeren; Martin Paul; and Marja van Dieijen, president and CEO of the Executive Board, Maastricht University.)


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in spectroscopy? Visit our sister site

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved